BioXcel Therapeutics Inc. Stock Prediction and Forecast [BTAI]

AI-generated source summary

BTAI stock has been ranked as a buy candidate since August 13, 2025, and as of August 26, 2025, the stock has a score of 3.11. Currently, the stock is in a broad and robust upward trend in the short term. Analysis of the recent three-month trend suggests a possibility of a change of -4.67% to 193.55% over the next three months. Over 12 months, a projected change of -58.99% is expected. Potential returns ranging from $0 to $2.64. A stop loss is suggested at $4.94 (-5.76%).

AI-generated summary based on the source content.

Evidence and evaluation progress

1. Original source published

   27 Aug 2025, 03:12 UTC

   The analyst published the original source item.

2. First prediction resolved

   27 Aug 2025, 13:30 UTC

   The first evaluable outcome in this case reached a terminal result.

3. Case evaluation completed

   27 Aug 2025, 13:30 UTC

   All evaluable predictions in this case reached terminal outcomes.

4. Source recorded by Tahlil Plus

   18 May 2026, 20:23 UTC

   The public source was preserved as the evidence record for this case.

5. Market predictions extracted

   18 May 2026, 20:47 UTC

   1 eligible signal linked to this case.

6. Outcome tracking started

   02 Jul 2026, 01:22 UTC

   Tahlil Plus began monitoring the extracted predictions.